sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Narcolepsy Market Scope And Analysis

  • Report Code : TIPRE00003326
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 153
Buy Now

Narcolepsy Market Report Scope 2021 to 2031

Buy Now

Narcolepsy Market Report Narcolepsy Market Size and Share Narcolepsy Market Scope and Analysis

Narcolepsy Market Report Scope

Report Attribute Details
Market size in 2018 US$ 2.03 Billion
Market Size by 2027 US$ 4.54 Billion
Global CAGR (2018 - 2027) 9.5%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Type
  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy
By Product
  • Central Nervous System Stimulants
  • Sodium Oxybate
  • Antidepressants
By Distribution Channel
  • Hospital Pharmacies and Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bioprojet
  • Teva Pharmaceutical Industries Ltd
  • Jazz Pharmaceuticals Inc
  • Graymark Healthcare Inc
  • Arena Pharmaceuticals Inc
  • Shire Acquired by Takeda
  • Ligand Pharmaceuticals Inc
  • Novartis AG
  • Mylan N V